| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Wellborn Gayle Furgurson serves as a Director at HQY. Across recent SEC filings that breaks down to 0 buys and 4 sells.
Historically, Wellborn Gayle Furgurson's trades have earned a below-average insider score of 36/100 across 3 rated trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -12.0%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 28, 2026 | HQY Healthequity, Inc. | Director | Sale+OE | 2,439 | $90.00 | $219,510.00 | -11.0% | +15.4% | - | |
| Dec 12, 2025 | HQY Healthequity, Inc. | Director | Sale+OE | 4,339 | $98.03 | $425,330.91 | -18.0% | -20.7% | - | |
| Jul 9, 2024 | HQY Healthequity, Inc. | Director | Sale+OE | 5,297 | $81.34 | $430,857.98 | -23.0% | +1.0% | +22.4% | |
| Dec 14, 2022 | HQY Healthequity, Inc. | Director | Sell | 5,237 | $62.00 | $324,694.00 | -30.3% | -8.5% | +1.6% |